home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Tired T Cells Get A Boost To Fight HIV

  August, 31 2006 6:08
your information resource in human molecular genetics
Blocking a protein called PD-1 (programmed death 1) might provide a way to boost the function of T cells crippled by HIV, according to two studies published online in Nature and Nature Medicine.

Earlier this year, a study showed that blocking the function of PD-1 in virally infected mice could restore the function of ailing T cells and help fight infection.

In the paper published in Nature, Bruce Walker and his colleagues have now examined seventy one chronically infected HIV patients and found that their T cells have dramatically more PD-1 receptors on their surface, and that the degree of PD-1 production correlates with markers of disease progression including the extent to which T cells are disabled and the levels of virus within the body.

In the Nature Medicine study, Rafick-Pierre Sekaly and his colleagues find similar correlations in nineteen HIV infected patients and show that, over time, fluctuations in HIV load mirror levels of PD-1 expression on the T cells.

Notably, both groups of researchers find that an antibody that blocks this receptor promotes the immune response to HIV in laboratory experiments, raising hope that a similar strategy might work to fight the disease in humans.

Author Contacts:

Nature paper
Bruce Walker (Partners AIDS Research Center, Boston, MA, USA)
E-mail: bwalker@partners.org

Nature Medicine paper
Rafick-Pierre Sekaly (Centre de Recherche du CHUM, Montreal, Canada)
E-mail: rafick-pierre.sekaly@umontreal.ca

(C) Nature press release.
(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.